Oregon Health and Science University (OSHU)

Frequency and characteristics of axial involvement in psoriatic arthritis: results from the International Multicentre AXIS Study (2026) Torgutalp M, Almodovar R, Azevedo VF, Baraliakos X, Bosch FVd, Braun J, Chandran V, et al. Journal article Validation of PARACELSUS score performance for the diagnosis of pyoderma gangrenosum: An international multicenter study with 1403 cases (2026) Moelleken M, Ortega-Loayza AG, Busch D, Erfurt-Berge C, Shinohara MM, Do A, Libertad Ortega Nuñez D, et al. Journal article Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes (2026) Pop-Busui R, Rasmussen S, Deanfield JE, Buse JB, Marx N, Mulvagh SL, Inzucchi SE, et al. Journal article Cholangiocarcinoma 2026: status quo, unmet needs and priorities (2026) Banales JM, Rodrigues PM, Affò S, Andersen JB, Aspichueta P, Boulter L, Bridgewater J, et al. Journal article, Review article Oral Semaglutide and Cardiovascular Outcomes in People With Type 2 Diabetes, According to SGLT2i Use: Prespecified Analyses of the SOUL Randomized Trial (2025) Marx N, Deanfield JE, Mann JF, Arechavaleta R, Bain SC, Bajaj HS, Bayer Tanggaard K, et al. Journal article MEIS1::NCOA1 Primitive Spindle Cell Sarcoma of the Kidney: Report of 7 Cases of a Distinctive Clinicopathologic Entity (2025) Argani P, Wangsiricharoen S, Tretiakova M, Liu YJ, Falzarano SM, Collins K, Brimo F, et al. Journal article Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (2025) McGuire DK, Marx N, Mulvagh SL, Deanfield JE, Inzucchi SE, Pop-Busui R, Mann JF, et al. Journal article Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials (2025) Lee MM, Sattar N, Pop-Busui R, Deanfield J, Emerson SS, Inzucchi SE, Mann JF, et al. Journal article Identifying research priorities for pituitary adenoma surgery: an international Delphi consensus statement (2025) Newall N, Valetopoulou A, Khan DZ, Borg A, Bouloux PM, Bremner F, Buchfelder M, et al. Journal article YAP1::KMT2A-rearranged sarcomas harbor a unique methylation profile and are distinct from sclerosing epithelioid fibrosarcoma and low-grade fibromyxoid sarcoma (2025) Warmke LM, Ameline B, Fritchie KJ, Dehner CA, Agaimy A, Din NU, Miettinen MM, et al. Journal article